Dr. Yaacov Anziska, M.D

Neurology Brooklyn, NY Male
NPI: 1821161258
Total Payments
$26,133
2024 Payments
$2,760
Companies
27
Transactions
60
Medicare Patients
310
Medicare Billing
$39,907

Payment Breakdown by Category

Consulting$23,952 (91.7%)
Food & Beverage$1,598 (6.1%)
Other$515.00 (2.0%)
Education$67.48 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $23,952 23 91.7%
Food and Beverage $1,598 32 6.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $515.00 2 2.0%
Education $67.48 3 0.3%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $4,777 3 $0 (2022)
Biogen, Inc. $3,444 6 $0 (2022)
VERTEX PHARMACEUTICALS INCORPORATED $3,093 9 $0 (2024)
Alexion Pharmaceuticals, Inc. $2,734 6 $0 (2024)
CATALYST PHARMACEUTICALS, INC. $2,500 2 $0 (2020)
Amgen Inc. $2,200 1 $0 (2024)
ARGENX US, INC. $1,188 1 $0 (2023)
PTC Therapeutics, Inc. $1,171 2 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $1,100 1 $0 (2023)
UCB, Inc. $1,013 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,760 7 Amgen Inc. ($2,200)
2023 $2,467 4 ARGENX US, INC. ($1,188)
2022 $10,884 12 GENZYME CORPORATION ($4,757)
2021 $986.23 4 Vertex Pharmaceuticals Incorporated ($973.33)
2020 $6,643 7 Biogen, Inc. ($3,150)
2019 $1,073 4 VERTEX PHARMACEUTICALS INCORPORATED ($580.00)
2018 $980.15 17 VERTEX PHARMACEUTICALS INCORPORATED ($373.33)
2017 $339.53 5 F. Hoffmann-La Roche AG ($282.00)

All Payment Transactions

60 individual payment records from CMS Open Payments — Page 2 of 3

Date Company Product Nature Form Amount Type
09/13/2021 Vertex Pharmaceuticals Incorporated — Consulting Fee Cash or cash equivalent $380.00 General
05/26/2021 Vertex Pharmaceuticals Incorporated — Consulting Fee Cash or cash equivalent $300.00 General
10/19/2020 CATALYST PHARMACEUTICALS, INC. FIRDAPSE (Drug) Consulting Fee Cash or cash equivalent $1,250.00 General
Category: NEUROLOGY
10/06/2020 Pacira Pharmaceuticals Incorporated EXPAREL (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $440.00 General
Category: PAIN MANAGEMENT
09/30/2020 CATALYST PHARMACEUTICALS, INC. FIRDAPSE (Drug) Consulting Fee Cash or cash equivalent $1,250.00 General
Category: NEUROLOGY
08/27/2020 VERTEX PHARMACEUTICALS INCORPORATED — Consulting Fee Cash or cash equivalent $393.33 General
07/21/2020 Biogen, Inc. — Consulting Fee Cash or cash equivalent $3,150.00 General
03/09/2020 Grifols USA, LLC Gamunex-C (Biological) Food and Beverage In-kind items and services $26.13 General
Category: Immunology and Neurology
01/23/2020 Sarepta Therapeutics, Inc. Exondys 51 (Drug) Food and Beverage In-kind items and services $133.27 General
Category: Genetic Disease
10/18/2019 Shire North American Group Inc GAMMAGARD LIQUID (Biological) Food and Beverage In-kind items and services $120.01 General
Category: IMMUNOLOGY
04/29/2019 VERTEX PHARMACEUTICALS INCORPORATED — Consulting Fee Cash or cash equivalent $193.33 General
04/12/2019 VERTEX PHARMACEUTICALS INCORPORATED — Consulting Fee Cash or cash equivalent $386.67 General
04/08/2019 Sentynl Therapeutics, Inc. — Consulting Fee Cash or cash equivalent $373.00 General
12/05/2018 Grifols USA, LLC Gamunex-C (Biological) Food and Beverage In-kind items and services $16.63 General
Category: Immunology and Neurology
11/28/2018 GENZYME CORPORATION AUBAGIO (Drug) Food and Beverage In-kind items and services $20.27 General
Category: MULTIPLE SCLEROSIS
10/17/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $23.08 General
Category: Immunology
10/12/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $11.38 General
Category: Immunology
10/10/2018 VERTEX PHARMACEUTICALS INCORPORATED — Consulting Fee Cash or cash equivalent $373.33 General
10/10/2018 Grifols USA, LLC Gamunex-C (Biological) Food and Beverage In-kind items and services $18.03 General
Category: Immunology and Neurology
09/29/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $15.11 General
Category: Immunology
09/07/2018 Allergan Inc. BOTOX - NEUROLOGY (Drug) Food and Beverage In-kind items and services $21.21 General
Category: NEUROSCIENCE
08/01/2018 Grifols USA, LLC Gamunex-C (Biological) Food and Beverage In-kind items and services $13.76 General
Category: Immunology and Neurology
07/08/2018 Sarepta Therapeutics, Inc. EXONDYS 51 (Drug) Food and Beverage In-kind items and services $86.99 General
Category: Genetic Disease
06/06/2018 Strongbridge US INC. KEVEYIS (Drug) Food and Beverage In-kind items and services $21.26 General
Category: Neurology
05/31/2018 Biogen, Inc. SPINRAZA (Biological) Education In-kind items and services $42.00 General
Category: NEUROLOGY
«123»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 92 108 $38,295 $9,823
2022 4 52 105 $33,963 $9,022
2021 5 80 109 $38,633 $10,736
2020 5 86 113 $41,270 $10,327
Total Patients
310
Total Services
435
Medicare Billing
$39,907
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 27 33 $12,606 $3,097 24.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 22 24 $12,072 $2,870 23.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 23 30 $8,115 $2,095 25.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 20 21 $5,502 $1,760 32.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 15 29 $11,078 $3,382 30.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 12 46 $12,374 $3,116 25.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 11 11 $5,533 $1,289 23.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 14 19 $4,978 $1,234 24.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 23 31 $8,122 $2,454 30.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 15 15 $8,730 $2,322 26.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 13 20 $7,640 $2,315 30.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 18 32 $8,608 $2,201 25.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 11 11 $5,533 $1,444 26.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 21 41 $11,029 $2,804 25.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 20 26 $9,932 $2,377 23.9%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 17 17 $8,551 $2,249 26.3%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 13 13 $7,566 $1,874 24.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 15 16 $4,192 $1,023 24.4%

About Dr. Yaacov Anziska, M.D

Dr. Yaacov Anziska, M.D is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821161258.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yaacov Anziska, M.D has received a total of $26,133 in payments from pharmaceutical and medical device companies, with $2,760 received in 2024. These payments were reported across 60 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($23,952).

As a Medicare-enrolled provider, Anziska has provided services to 310 Medicare beneficiaries, totaling 435 services with total Medicare billing of $39,907. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Brooklyn, NY
  • Active Since 11/15/2006
  • Last Updated 02/16/2024
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1821161258

Products in Payments

  • LUMIZYME (Biological) $4,672
  • FIRDAPSE (Drug) $2,500
  • UPLIZNA (Biological) $2,200
  • VYVGART (Drug) $1,188
  • EMFLAZA (Drug) $1,171
  • EXPAREL (Drug) $440.00
  • BRUKINSA (Drug) $320.00
  • SPINRAZA (Biological) $293.60
  • EXONDYS 51 (Drug) $230.99
  • BOTOX (Biological) $179.38
  • Exondys 51 (Drug) $133.27
  • GAMMAGARD LIQUID (Biological) $120.01
  • Evrysdi (Drug) $98.81
  • Gamunex-C (Biological) $93.68
  • ULTOMIRIS (Biological) $57.56
  • SOLIRIS (Drug) $49.57
  • KEVEYIS (Drug) $40.61
  • Radicava (Drug) $25.48
  • RYTARY (Drug) $24.05
  • BOTOX - NEUROLOGY (Drug) $21.21

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Brooklyn

Karen Blitz-Shabbir, Do, DO

Neurology — Payments: $393,441

Neurology $393,441

Miss. Larisa Syrow, Md, MD

Neurology — Payments: $182,526

Neurology $182,526

Nada Abou-Fayssal, Md, MD

Neurology — Payments: $126,065

Neurology $126,065

Robyn Wolintz, Md, MD

Neurology — Payments: $123,772

Neurology $123,772

Miran Salgado, Md, MD

Neurology — Payments: $101,072

Neurology $101,072

Dr. Dmitriy Grinshpun, M.d, M.D

Neurology — Payments: $96,680

Neurology $96,680